Mosaic ImmunoEngineering CPMV
OTC CPMV
$0.06 +0.00 (+0.00%)
At close: Sep 30, 2026 · 4:00 PM EDT

Mosaic ImmunoEngineering (CPMV) Accumulated Depreciation (2012 - 2013)

Updated

Mosaic ImmunoEngineering (CPMV) posted Accumulated Depreciation of $44,839 for Q4 2013, up 0.4% from $44,667 a year earlier.

Analysis

Mosaic ImmunoEngineering (CPMV) Accumulated Depreciation (2012 - 2013) Analysis & Trends

  • In prior years, Mosaic ImmunoEngineering's Accumulated Depreciation was $44,667 in FY2012.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn
10 Mosaic ImmunoEngineering 434,528.21 434,528.21 -
Historic Data

Historic Data

Download Data
DateValue
May 31, 2013 44,839.00
May 31, 2012 44,667.00
API Access

Mosaic ImmunoEngineering Accumulated Depreciation API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=accumulated-depreciation&ticker=CPMV&period=max&api_key=YOUR_API_KEY